Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03915847
Other study ID # ATA35
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 16, 2019
Est. completion date April 16, 2020

Study information

Verified date May 2020
Source Ataturk University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study compares three techniques of uterine closure on myometrium thickness at the site of uterine scar of women who underwent repeated cesarean section. Cesarean scar will be evaluated by transvaginal ultrasound six months after cesarean.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date April 16, 2020
Est. primary completion date April 16, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Previous two or three cesarean

- Gestational weeks >=36 weeks

Exclusion Criteria:

- Risk of obstetric haemorrhage

- Suspicion or diagnosis placenta previa or accrete syndrome

- Chorioamnionitis

- Uterine myoma in the anterior uterine segment

- Hysterotomy other than lower segment uterine incision at previous cesarean

Study Design


Intervention

Procedure:
Single layer closure
Uterine incision will be approximated with continuous unlocked suture, including a narrow band of the endometrial layer, without trimming incision edges.
Double layer closure
The first layer suture penetrated the whole thickness of the uterine wall, including a narrow band of the endometrial layer. Second layer sture is acontinous sture performed in a lateral-to lateral position , imbricating first layer.
Doble layer closure with trimming
Uterine incision will be trimmed and old scar tissue will be removed. The first layer suture penetrated the whole thickness of the uterine wall, including a narrow band of the endometrial layer. Second layer sture is acontinous sture performed in a lateral-to lateral position , imbricating first layer.

Locations

Country Name City State
Turkey Ataturk University Hospital Erzurum

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Residual myometrial thickness Myometrial thickness at the uterine scar by transvaginal ultrasound 6 months after cesarean
Secondary Existence of cesarean scar defect The presence or absence of a cesarean scar defect that was defined as any unechogenic area visualised by transvaginal ultrasound at the site of the cesarean scar with a depth of at least 2 mm. 6 months after cesarean
Secondary Width of defect In a sagittal plane, the width at base of defect 6 months after cesarean
Secondary Depth of defect (niche) In a sagittal plane, the distance from the base lining of the endometrium to the apex 6 months after cesarean
Secondary Operation time Skin-to-skin operation time 10 minute after cesarean completed
Secondary Change in hemoglobin Difference in haemoglobin measured preoperatively and postoperatively 48 hours 48 hours after cesarean
Secondary Blood product transfusion Unite number of transfused packed erythrocyte One week after cesarean
Secondary Maternal infectious morbidity Prevalence of postpartum endometritis, skin wound dehiscence and post operative fever. Six weeks after cesarean
Secondary Length of hospitalization Duration in days One month after cesarean
See also
  Status Clinical Trial Phase
Recruiting NCT03644433 - Impact of Uterine Closure Techniques on the Cesarean Scar Thickness After Repeated Cesarean Section N/A